T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Immunotherapy is gaining traction as a prominent approach to cancer treatment. These therapies encompass the use of Chimeric ...

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable ...

The brain is a unique place. It is shielded from much of the body by the blood-brain barrier, meaning it's protected from ...

Adding IL-12 to mRNA vaccines can lead to longer lasting protective effect and a potential approach for reducing the risk of ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

CAR-T cell therapy, which involves genetically engineered T-lymphocytes targeting cancer cells, has shown high efficacy in blood cancers and is being explored for solid tumors and autoimmune diseases.

T-cells engineered to express both chimeric antigen receptors (CARs) and T-cell receptors (TCRs) show improved discrimination between cancerous and healthy tissues.